News
Press Releases
Seqens confirms the acquisition of CELLforCURE
SEQENS confirms the acquisition of the CELLforCURE site at Les Ulis (91) from NOVARTIS as of December 1st, 2023.
Events and more
01
November 11-12 / London, UK
//Meet us booth #37//
Follow our presentation, November 12 at 11.15 AM
Track 2: Strategies for Cell Therapy Manufacturing
02
November 18-19 / Philadelphia , PA
//Meet us booth #818 //
The event is designed for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.
03
Novembre 27–28, Göteborg SE
//Meet us booth #1// ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells, or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. The event aims to promote collaboration and communication needed for accelerated, effective ATMP-based patient solutions.
04
December 1-2nd DE
//Join us in Berlin// Transforming Scientific Promise into Therapeutic Progress. Design Targeted Cell & Gene Therapies. Master Manufacturing. Accelerate Patient Access.
05
December 2-4, Philadelphia, PA
//Meet us at the 3rd Cell Therapy for Autoimmune Disease Summit returns at a transformative moment for this field, as autoimmune therapies stand poised to lead the next frontier of cell therapy innovation. As the only forum spotlighting breakthroughs across CAR-T, Treg, NK and in vivo cell therapies, this is your opportunity to gain end-to-end insights to navigate the dynamic, high-velocity road to market.
